258 related articles for article (PubMed ID: 20890046)
21. Adoptive immunotherapy of disseminated leukemia with TCR-transduced, CD8+ T cells expressing a known endogenous TCR.
Dossett ML; Teague RM; Schmitt TM; Tan X; Cooper LJ; Pinzon C; Greenberg PD
Mol Ther; 2009 Apr; 17(4):742-9. PubMed ID: 19209146
[TBL] [Abstract][Full Text] [Related]
22. Control of virus-specific CD8+ T-cell exhaustion and immune-mediated pathology by E3 ubiquitin ligase Cbl-b during chronic viral infection.
Ou R; Zhang M; Huang L; Moskophidis D
J Virol; 2008 Apr; 82(7):3353-68. PubMed ID: 18199651
[TBL] [Abstract][Full Text] [Related]
23. Overproduction of IFNγ by Cbl-b-Deficient CD8+ T Cells Provides Resistance against Regulatory T Cells and Induces Potent Antitumor Immunity.
Han S; Liu ZQ; Chung DC; Paul MS; Garcia-Batres CR; Sayad A; Elford AR; Gold MJ; Grimshaw N; Ohashi PS
Cancer Immunol Res; 2022 Apr; 10(4):437-452. PubMed ID: 35181779
[TBL] [Abstract][Full Text] [Related]
24. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions.
Paolino M; Thien CB; Gruber T; Hinterleitner R; Baier G; Langdon WY; Penninger JM
J Immunol; 2011 Feb; 186(4):2138-47. PubMed ID: 21248250
[TBL] [Abstract][Full Text] [Related]
25. The stoichiometric production of IL-2 and IFN-γ mRNA defines memory T cells that can self-renew after adoptive transfer in humans.
Wang A; Chandran S; Shah SA; Chiu Y; Paria BC; Aghamolla T; Alvarez-Downing MM; Lee CC; Singh S; Li T; Dudley ME; Restifo NP; Rosenberg SA; Kammula US
Sci Transl Med; 2012 Aug; 4(149):149ra120. PubMed ID: 22932225
[TBL] [Abstract][Full Text] [Related]
26. Protein Tyrosine Phosphatase SHP-1 Modulates T Cell Responses by Controlling Cbl-b Degradation.
Xiao Y; Qiao G; Tang J; Tang R; Guo H; Warwar S; Langdon WY; Tao L; Zhang J
J Immunol; 2015 Nov; 195(9):4218-27. PubMed ID: 26416283
[TBL] [Abstract][Full Text] [Related]
27. Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination.
Zhang J; Bárdos T; Li D; Gál I; Vermes C; Xu J; Mikecz K; Finnegan A; Lipkowitz S; Glant TT
J Immunol; 2002 Sep; 169(5):2236-40. PubMed ID: 12193687
[TBL] [Abstract][Full Text] [Related]
28. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
Yoshizawa H; Chang AE; Shu SY
Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
[TBL] [Abstract][Full Text] [Related]
29. CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.
Hervas-Stubbs S; Mancheño U; Riezu-Boj JI; Larraga A; Ochoa MC; Alignani D; Alfaro C; Morales-Kastresana A; Gonzalez I; Larrea E; Pircher H; Le Bon A; Lopez-Picazo JM; Martín-Algarra S; Prieto J; Melero I
J Immunol; 2012 Oct; 189(7):3299-310. PubMed ID: 22925929
[TBL] [Abstract][Full Text] [Related]
30. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo.
Wohlfert EA; Gorelik L; Mittler R; Flavell RA; Clark RB
J Immunol; 2006 Feb; 176(3):1316-20. PubMed ID: 16424156
[TBL] [Abstract][Full Text] [Related]
31. PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation.
Gruber T; Hermann-Kleiter N; Hinterleitner R; Fresser F; Schneider R; Gastl G; Penninger JM; Baier G
Sci Signal; 2009 Jun; 2(76):ra30. PubMed ID: 19549985
[TBL] [Abstract][Full Text] [Related]
32. Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells.
Krawczyk C; Bachmaier K; Sasaki T; Jones RG; Snapper SB; Bouchard D; Kozieradzki I; Ohashi PS; Alt FW; Penninger JM
Immunity; 2000 Oct; 13(4):463-73. PubMed ID: 11070165
[TBL] [Abstract][Full Text] [Related]
33. Adoptive T Cell Therapy with IL-12-Preconditioned Low-Avidity T Cells Prevents Exhaustion and Results in Enhanced T Cell Activation, Enhanced Tumor Clearance, and Decreased Risk for Autoimmunity.
Tucker CG; Mitchell JS; Martinov T; Burbach BJ; Beura LK; Wilson JC; Dwyer AJ; Singh LM; Mescher MF; Fife BT
J Immunol; 2020 Sep; 205(5):1449-1460. PubMed ID: 32737148
[TBL] [Abstract][Full Text] [Related]
34. CD28 activation does not down-regulate Cbl-b expression in aged rat T-lymphocytes.
Xu Z; George C; Jolly CA
Mech Ageing Dev; 2004 Sep; 125(9):595-602. PubMed ID: 15491677
[TBL] [Abstract][Full Text] [Related]
35. IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer.
Heon EK; Wulan H; Macdonald LP; Malek AO; Braunstein GH; Eaves CG; Schattner MD; Allen PM; Alexander MO; Hawkins CA; McGovern DW; Freeman RL; Amir EP; Huse JD; Zaltzman JS; Kauff NP; Meyers PG; Gleason MH; Overholtzer MG; Wiseman SS; Streutker CD; Asa SW; McAlindon TP; Newcomb PO; Sorensen PM; Press OA
Biochem Biophys Res Commun; 2015 Aug; 464(1):360-6. PubMed ID: 26141233
[TBL] [Abstract][Full Text] [Related]
36. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity.
Kemp RA; Ronchese F
J Immunol; 2001 Dec; 167(11):6497-502. PubMed ID: 11714817
[TBL] [Abstract][Full Text] [Related]
37. Cbl-b gene silencing in splenic T lymphocytes as a therapeutic strategy to target the prostate cancer RM-1 cell tumors in immune competent mice.
Shi ZD; Li XF; Hao L; Zhao Y; Wang YX; Dong BZ; Chen WH; Zhang ZG; Wang YM; Fu Q; Han CH; Li S
Eur Rev Med Pharmacol Sci; 2014; 18(24):3819-30. PubMed ID: 25555872
[TBL] [Abstract][Full Text] [Related]
38. Effector CD8+ T cells activated in vitro confer immediate and long-term tumor protection in vivo.
Perret R; Ronchese F
Eur J Immunol; 2008 Oct; 38(10):2886-95. PubMed ID: 18825745
[TBL] [Abstract][Full Text] [Related]
39. CBLB Constrains Inactivated Vaccine-Induced CD8
Nanjappa SG; Mudalagiriyappa S; Fites JS; Suresh M; Klein BS
J Immunol; 2018 Sep; 201(6):1717-1726. PubMed ID: 30054317
[TBL] [Abstract][Full Text] [Related]
40. Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b).
Zhou L; Yang J; Zhang K; Wang T; Jiang S; Zhang X
J Med Chem; 2024 Jan; 67(2):816-837. PubMed ID: 38181380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
